Prussian Blue: an Artistic and Diagnostic Odyssey
-
By
-
Ebubekir (Bekir) Ucar
-
June 5, 2026
By
Ebubekir (Bekir) Ucar
June 5, 2026
by Ebubekir (Bekir) Ucar
June 5, 2026
A patented AI platform trained on NYU Langone research is predicting cancer mutations from haematoxylin and eosin alone — closing the gap for the 25 percent of patients who never reach molecular testing
June 4, 2026
Researchers assess long-read sequencing for infertility and recurrent pregnancy loss diagnostics
June 2, 2026